Elcelyx Overview

  • Founded
  • 2010
Founded
  • Status
  • Out of Business
  • Employees
  • 19
Employees
  • Latest Deal Type
  • Out of Business

Elcelyx General Information

Description

Developer of nutrient based products designed to treat diabetes, weight management and obesity-related metabolic disorders. The company's products include Lovidia(TM) and NewMet(TM) amplifies the release of hormones, enabling patients to improve glucose metabolism without systemic side effects.

Contact Information

Website
www.elcelyx.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Food Products
Primary Office
  • 11975 El Camino Real
  • Suite 305
  • San Diego, CA 92130
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elcelyx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 17-Jan-2020 000.00 Completed Out of Business
6. Later Stage VC 07-Nov-2018 00000 000.00 Completed Generating Revenue
5. Later Stage VC (Series E) 01-Oct-2015 0000 000.00 00000 Completed Generating Revenue
4. Later Stage VC (Series D) 18-Feb-2015 00.000 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 24-Feb-2014 000.00 000.00 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 20-Dec-2012 $21.1M $23.1M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 18-Mar-2010 $2M $2M 00.000 Completed Generating Revenue
To view Elcelyx’s complete valuation and funding history, request access »

Elcelyx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series D 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series C1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B1 2,917,930 $0.000100 $0.34 $4.29 $4.29 1x $3.51 8.93%
Series A1 616,109 $0.000100 $0.13 $1.76 $1.76 1x $1.76 1.54%
To view Elcelyx’s complete cap table history, request access »

Elcelyx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of nutrient based products designed to treat diabetes, weight management and obesity-related metabolic disorde
Biotechnology
San Diego, CA
19 As of 2015
000.00
00000000 00 000.00

0000000

it esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000 000000000
Boston, MA
00 As of 0000
00000
000000000 00000

00000000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000000
Pasadena, CA
000 As of 0000
00.000
000000 - 000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Elcelyx Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gelesis Formerly VC-backed Boston, MA 00 00000 000000000 00000
000000000 00000000 Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
0000000 0000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000&0 00000
000000 00000000000 Venture Capital-Backed Cambridge, MA 00 00000 00000000000 00000
00000 000000000000 Venture Capital-Backed South San Francisco, CA 00 00000 000000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

Elcelyx Patents

Elcelyx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2012363873-B2 Biguanide compositions and methods of treating metabolic disorders Active 06-Jan-2012 0000000000 0
AU-2012363873-A1 Biguanide compositions and methods of treating metabolic disorders Granted 06-Jan-2012 0000000000
CA-2862533-C Biguanide compositions and methods of treating metabolic disorders Active 06-Jan-2012 0000000000
JP-2020007348-A Biguanide composition and method for treating metabolic disorder Pending 06-Jan-2012 0000000000
CA-2862533-A1 Biguanide compositions and methods of treating metabolic disorders Granted 06-Jan-2012 A61K31/155
To view Elcelyx’s complete patent history, request access »

Elcelyx Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial